Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Ann Surg Oncol. 2023 Jun;30(6):3188-3190. doi: 10.1245/s10434-023-13262-4. Epub 2023 Feb 25.

Authors

Nolan M Winicki¹, Isabella S Florissi¹, Shannon N Radomski¹, Fabian M Johnston¹, Jonathan B Greer²

Affiliations

¹ Division of Gastrointestinal Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Division of Gastrointestinal Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jgreer13@jhmi.edu.

PMID: 36840862
PMCID: PMC10428077 (available on 2024-06-01)
DOI: 10.1245/s10434-023-13262-4

No abstract available

Publication types

Letter

MeSH terms

Anemia, Iron-Deficiency* / drug therapy
Anemia, Iron-Deficiency* / therapy
Combined Modality Therapy
Cytoreduction Surgical Procedures / adverse effects
Humans
Hyperthermia, Induced* / adverse effects
Hyperthermic Intraperitoneal Chemotherapy
Peritoneal Neoplasms* / surgery

Grants and funding